Intravitreal enzyme replacement therapy to prevent retinal disease progression in children with neuronal ceroid lipofuscinosis type 2 (CLN2): Unilateral injection results

被引：0
|
作者：
Rogers, David L. [1 ]
de los Reyes, Emily C. [1 ]
Mendel, Thomas A. [2 ]
Caprul, Brian J. [1 ]
Podlasiak, Sarah [1 ]
Jordan, Catherine O. [1 ]
机构：
[1] Nationwide Childrens Hosp, Columbus, OH USA
[2] Ohio State Univ, Wexner Med Ctr, Columbus, OH USA
来源：
MOLECULAR GENETICS AND METABOLISM | 2024年 / 141卷 / 02期
关键词：
D O I：
10.1016/j.ymgme.2023.108019
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
280
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Intravitreal enzyme replacement therapy to prevent retinal disease progression in children with neuronal ceroid lipofuscinosis type 2 (CLN2): Interim safety report
    Rogers, David L.
    de los Reyes, Emily C.
    Caprul, Brian J.
    Mendel, Thomas A.
    Jordan, Catherine O.
    MOLECULAR GENETICS AND METABOLISM, 2023, 138 (02) : 112 - 113
  • [2] Intravitreal enzyme replacement therapy attenuates retinal disease progression in a canine model of neuronal ceroid lipofuscinosis type 2 (CLN2)
    Sinclair, John
    Whiting, Rebecca
    Robinson, Grace
    Bibi, Katherine
    Nguyen, Annailsa
    Cherukuri, Anu
    Henshaw, Joshua
    De Hart, Gregory
    Chandra, Sundeep
    O'Neill, Chuck
    Katz, Martin
    MOLECULAR GENETICS AND METABOLISM, 2018, 123 (02) : S132 - S132
  • [3] Intravitreal Enzyme replacement therapy attenuates retinal disease progression in a canine model of neuronal ceroid lipofuscinosis type 2 (CLN2)
    Sinclair, John
    Whiting, Rebecca
    Robinson, Grace
    Bibi, Katherin
    Nguyen, Annalisa
    Cherukuri, Anu
    Henshaw, Joshua
    de Hart, Gregory
    Sundeep, Chandra
    O'Neil, Chuck
    Katz, Martin
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [4] Intravitreal enzyme replacement inhibits progression of retinal degeneration in canine CLN2 neuronal ceroid lipofuscinosis
    Whiting, Rebecca E. H.
    Kick, Grace Robinson
    Ota-Kuroki, Juri
    Lim, Stefanie
    Castaner, Leilani J.
    Jensen, Cheryl A.
    Kowal, Joseph
    Nguyen, Annalisa
    Corado, Carley
    O'Neill, Charles A.
    Katz, Martin L.
    EXPERIMENTAL EYE RESEARCH, 2020, 198
  • [5] Intravitreal enzyme replacement preserves retinal structure and function in canine CLN2 neuronal ceroid lipofuscinosis
    Whiting, Rebecca E. H.
    Pearce, Jacqueline W.
    Vansteenkiste, Daniella P.
    Bibi, Katherine
    Lim, Stefanie
    Kick, Grace Robinson
    Castaner, Leilani J.
    Sinclair, John
    Chandra, Sundeep
    Nguyen, Annalisa
    O'Neill, Charles A.
    Katz, Martin L.
    EXPERIMENTAL EYE RESEARCH, 2020, 197
  • [6] Intravitreal gene therapy preserves retinal function in a canine model of CLN2 neuronal ceroid lipofuscinosis
    Kick, Grace Robinson
    Whiting, Rebecca E. H.
    Ota-Kuroki, Juri
    Castaner, Leilani J.
    Morgan-Jack, Brandie
    Sabol, Julianna C.
    Meiman, Elizabeth J.
    Ortiz, Francheska
    Katz, Martin L.
    EXPERIMENTAL EYE RESEARCH, 2023, 226
  • [7] Enzyme Replacement Therapy Attenuates Disease Progression in a Canine Model of Late-Infantile Neuronal Ceroid Lipofuscinosis (CLN2 Disease)
    Katz, Martin L.
    Coates, Joan R.
    Sibigtroth, Christine M.
    Taylor, Jacob D.
    Carpentier, Melissa
    Young, Whitney M.
    Wininger, Fred A.
    Kennedy, Derek
    Vuillemenot, Brian R.
    O'Neill, Charles A.
    JOURNAL OF NEUROSCIENCE RESEARCH, 2014, 92 (11) : 1591 - 1598
  • [8] Ongoing retinal degeneration despite intraventricular enzyme replacement therapy with cerliponase alfa in late-infantile neuronal ceroid lipofuscinosis type 2 (CLN2 disease)
    Dulz, Simon
    Schwering, C.
    Wildner, Jan
    Spartalis, Christoph
    Schuettauf, Frank
    Bartsch, Udo
    Wibbeler, Eva
    Nickel, Miriam
    Spitzer, Martin Stephan
    Atiskova, Yevgeniya
    Schulz, Angela
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2023, 107 (10) : 1478 - 1483
  • [9] Ongoing retinal degeneration despite intraventricular enzyme replacement therapy with cerliponase alfa in late-infantile neuronal ceroid lipofuscinosis type 2 (CLN2 disease)
    Dulz, Simon
    Schwering, C.
    Wildner, Jan
    Spartalis, Christoph
    Schuettauf, Frank
    Bartsch, Udo
    Wibbeler, Eva
    Nickel, Miriam
    Spitzer, Martin Stephan
    Atiskova, Yevgeniya
    Schulz, Angela
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2022,
  • [10] Atypical neuronal ceroid lipofuscinosis type 2 (CLN2 disease): A case report
    Curiati Mendes, Carmen Silvia
    Rand, Maret
    Curiati, Marco A.
    Martins, Ana M.
    MOLECULAR GENETICS AND METABOLISM, 2020, 129 (02) : S44 - S44
12345